Kenji Arakawa
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Oct 07, 2025
Real-world use of HIF-PH inhibitors and ESAs in non-dialysis-dependent CKD with anaemia: insights from a Japanese database study.Kiichiro Ueta, Manabu Ishii, Akira Oku
|Mar 30, 2024
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study.Akiko Takahashi, Manabu Ishii, Yurika Kino
|Jul 20, 2022
Effect of sodium-glucose cotransporter 2 inhibitor medication on new prescriptions of antihypertensives, antigout/antihyperuricemics and antidyslipidemics in Japan: Analysis using the JMDC Claims Database.Maki Gouda, Kenji Arakawa, Masaya Inagaki
|Jul 02, 2021
Renal, cardiovascular and safety outcomes of canagliflozin in patients with type 2 diabetes and nephropathy in East and South-East Asian countries: Results from the Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation Trial.Takashi Wada, Kazumi Mori-Anai, Yutaka Kawaguchi
Pageof 1
